ArticleJournal of thoracic disease2026

Real-world effectiveness and safety of adjuvant atezolizumab in pathological stage IIA-IIIB non-small cell lung cancer following curative surgery.

Akifumi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.